Li, X., Fang, T., Xu, S., Jin, P., Zhou, D., Wang, Z., . . . Gao, Q. (2021). PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer. Nature Portfolio.
Style de citation Chicago (17e éd.)Li, Xiaoting, et al. PARP Inhibitors Promote Stromal Fibroblast Activation by Enhancing CCL5 Autocrine Signaling in Ovarian Cancer. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Li, Xiaoting, et al. PARP Inhibitors Promote Stromal Fibroblast Activation by Enhancing CCL5 Autocrine Signaling in Ovarian Cancer. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.